Pfizer Inc (PFE)

Feb 22, 2025, 9:00 AM EST - 9 hours ago

Pfizer: No More Growth - Still A Worthy Dividend Buy

Feb 20, 2025, 3:02 PM EST - 2 days ago

Pfizer says it will end global development of gene therapy Beqvez, Nikkei reports

Feb 20, 2025, 8:45 AM EST - 2 days ago

Dividend Harvesting Portfolio Week 207: $20,700 Allocated, $2,010.09 In Projected Dividends

BST MO O PDI QQQI STWD UTG

Feb 19, 2025, 6:07 PM EST - 3 days ago

10 Ideal 'Safer' January Dividend Buys, Out Of 40 Choices From Readers

ARR CAG CCIF DOW FRO FSK GOGL

Feb 19, 2025, 8:09 AM EST - 3 days ago

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

BMY OGN

Feb 19, 2025, 7:22 AM EST - 3 days ago

Why Pfizer's Stock Price Isn't Reflecting Its True Value

Feb 19, 2025, 3:31 AM EST - 3 days ago

Pfizer Stock's Upside Got Bigger

Feb 18, 2025, 5:18 PM EST - 4 days ago

Pfizer CEO Albert Bourla: Focusing on opportunities outside of vaccines with RFK Jr.

Feb 17, 2025, 1:27 AM EST - 5 days ago

Pfizer: Danuglipron Could Tip The Scale In A Few Years, But For Now, Sell

Feb 16, 2025, 7:53 AM EST - 6 days ago

Buy 5 'Safer' Dividend Dogs Of 23 February Barron's Better Bets Than T-Bills

AG BBY BMY EQR ETR FRT KEY

Feb 13, 2025, 1:53 PM EST - 9 days ago

The Big 3: AMSC, PFE, GOLD

AMSC GOLD

Feb 13, 2025, 10:00 AM EST - 9 days ago

Pfizer's TALZENNA® in Combination with XTANDI® Improves Survival Outcomes in Metastatic Castration Resistant Prostate Cancer

Feb 12, 2025, 12:15 PM EST - 10 days ago

U.S. FDA Approves Pfizer's ADCETRIS® Combination Regimen for the treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Feb 12, 2025, 6:04 AM EST - 10 days ago

Pfizer: 3 Key Risks That Warrant A Sell

Feb 11, 2025, 8:30 AM EST - 11 days ago

Alloy Therapeutics Establishes Multi-Year Collaboration with Pfizer to Develop New Antibody Discovery Platform

Feb 10, 2025, 5:00 PM EST - 12 days ago

Pfizer and Astellas' PADCEV® (enfortumab vedotin-ejfv) plus KEYTRUDA® (pembrolizumab) Shows Long-Term Efficacy in First-Line Treatment of Locally Advanced or Metastatic Urothelial Cancer (la/mUC)

Feb 10, 2025, 3:28 PM EST - 12 days ago

A Historic Opportunity To Win Big With Dividend Stocks

AMLP ARCC ARE BIZD CVX DKL GBDC

Feb 10, 2025, 9:39 AM EST - 12 days ago

Pfizer: Challenges Loom Amid Overvaluation

Feb 9, 2025, 10:06 AM EST - 13 days ago

Fighting Cancer Becomes Top Priority for Pfizer

Feb 8, 2025, 8:00 AM EST - 14 days ago

Income Strategy: I'm Stashing Cash Into These Wonderful Dividends

ABBV

Feb 5, 2025, 3:45 PM EST - 17 days ago

These S&P 500 Stocks Yield 6%. They Could Be Better Than Bonds.

MO VZ WBA

Feb 5, 2025, 11:18 AM EST - 17 days ago

Should You Pick PFE Stock At $25?

Feb 5, 2025, 10:35 AM EST - 17 days ago

MoneyShow's Best Investment Ideas For 2025: Part 9

ASM IIPR IMO ITRN PSLV TBBB

Feb 4, 2025, 3:43 PM EST - 18 days ago

Pfizer, Inc. (PFE) Q4 2024 Earnings Call Transcript

Feb 4, 2025, 12:21 PM EST - 18 days ago

Nasdaq Surges Over 1%; Pfizer Earnings Top Estimates

Feb 4, 2025, 11:51 AM EST - 18 days ago

Vaccine, packaged food stocks fall as Kennedy moves closer to health secretary job

BNTX MRNA NVAX GIS HSY KHC MDLZ

Feb 4, 2025, 11:50 AM EST - 18 days ago

Vaccine stocks fall as Senate panel advances RFK Jr.'s nomination for HHS secretary

BNTX MRNA NVAX GSK

Feb 4, 2025, 8:35 AM EST - 18 days ago

Mizuho's Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocks

MRK

Feb 4, 2025, 8:22 AM EST - 18 days ago

Pfizer stock climbs on Q4 revenue and earnings beat, reaffirmed guidance

Feb 4, 2025, 7:12 AM EST - 18 days ago

Pfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay off

Feb 4, 2025, 6:53 AM EST - 18 days ago

Pfizer beats fourth-quarter profit estimates on cost-cutting efforts

Feb 4, 2025, 6:45 AM EST - 18 days ago

Pfizer Reports Strong Full-Year 2024 Results And Reaffirms 2025 Guidance

Feb 4, 2025, 4:15 AM EST - 18 days ago

Pfizer Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Feb 3, 2025, 1:49 PM EST - 19 days ago

Merck Vs. Pfizer: Which Pharmaceutical Giant Will Prevail In Q4 Earnings?

MRK

Feb 3, 2025, 6:45 AM EST - 19 days ago

Pfizer's BRAFTOVI® Combination Regimen Significantly Improved Progression-Free Survival and Overall Survival in Phase 3 BREAKWATER Trial

Feb 3, 2025, 6:03 AM EST - 19 days ago

Smaller US winter COVID wave adds pressure to Pfizer turnaround

Jan 31, 2025, 5:25 PM EST - 22 days ago

Pfizer resolves conservative challenge to diversity fellowship program

Jan 30, 2025, 7:00 AM EST - 23 days ago

Dividends And Dynamite: 10 High-Yield Blue-Chip Bargains You Don't Want To Miss

ASML BNS BTI EPD GOOGL ILMN NVDA

Jan 29, 2025, 9:00 AM EST - 24 days ago

10 Undervalued Dividend Growth Stocks: January 2025

BMY HRL HSY KMB NVS PEP SPY

Jan 28, 2025, 3:11 PM EST - 25 days ago

Pfizer Q4 Earnings Preview: 5 Critical Business Issues To Consider

Jan 28, 2025, 6:45 AM EST - 25 days ago

Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium

Jan 27, 2025, 2:23 PM EST - 26 days ago

Pfizer's Conditionally Approved Braftovi Combo Therapy Regime Shows Improved Response In Colorectal Cancer Patients

Jan 25, 2025, 3:00 PM EST - 4 weeks ago

Pfizer's BRAFTOVI® Combination Regimen Demonstrates Improved Response in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer

Jan 25, 2025, 7:31 AM EST - 4 weeks ago

Is it safe to buy these high-yielding S&P 500 stocks?

F MO WBA

Jan 24, 2025, 5:55 PM EST - 4 weeks ago

Pfizer to pay $59.7 million over kickbacks for migraine drug

Jan 23, 2025, 4:17 AM EST - 4 weeks ago

How To Invest $100,000 In The Ten Cheapest Dow Dividend 100 Stocks

ABBV AMGN BLK BMY CSCO CVX EOG

Jan 23, 2025, 4:02 AM EST - 4 weeks ago

Peri-implantitis Market Research 2025-2030: Analysis of Growth Trends and Leading Competitors, Featuring Pfizer, Cadila Pharmaceuticals, GaronitPharma, Basic Pharma Life Science, Prachi Pharmaceuticals & More

Jan 21, 2025, 2:35 PM EST - 4 weeks ago

Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?

GSK ITCI JNJ LLY NVO

Jan 21, 2025, 6:42 AM EST - 4 weeks ago

Rose's Income Garden Portfolio Revealed: Yield 6.2%/Defensive Sector Winners

BCE BTI CVS DNP JBBB KEN MO